Inhibition of translation plays a role in apoptosis induced by a variety of stimuli, but the mechanism by which it promotes apoptosis has not been established. We have investigated the hypothesis that selective degradation of anti-apoptotic regulatory protein(s) is responsible for apoptosis resulting from translation inhibition. Induction of apoptosis by cycloheximide was detected within 2-4 h and blocked by proteasome inhibitors, indicating that degradation of shortlived protein ( 
Most signals that control survival of mammalian cells modulate the activity of Bcl-2 family members, which regulate the mitochondrial pathway of apoptosis (1, 2) . Anti-apoptotic members of the Bcl-2 family, including Bcl-2, Bcl-x L , and Mcl-1, maintain cell survival by inhibiting the pro-apoptotic Bcl-2 proteins Bak and Bax through protein-protein interactions. Bak and Bax are typically activated by a second set of pro-apoptotic Bcl-2 proteins called BH3-only proteins that associate with anti-apoptotic Bcl-2 proteins through interactions that displace and activate Bak and Bax. Once activated, Bak and Bax permeabilize the mitochondrial outer membrane, resulting in the release of cytochrome c and other pro-apoptotic factors that induce caspase activation and cell death.
Signaling pathways that regulate apoptosis can directly modify Bcl-2 family proteins, as well as alter the expression of Bcl-2 family members at both the transcriptional and translational levels. Many signaling pathways that regulate apoptosis target specific BH3-only proteins. For example, p53-mediated apoptosis involves transcriptional induction of the BH3-only proteins PUMA (3, 4) and Noxa (5), whereas PI 3 3-kinase/Akt signaling inhibits apoptosis through transcriptional repression of the BH3-only protein Bim (8) and phosphorylation of the BH3-only protein Bad, resulting in its sequestration by 14-3-3 proteins (6, 7) .
In addition to regulating Bcl-2 family proteins, many of the signaling pathways that control apoptosis affect global translational activity, generally by regulation of the initiation factors eIF2, eIF2B, and eIF4E (9 -11) . A variety of stimuli that induce cell stress inhibit translation via phosphorylation of eIF2, which brings the initiating methionyl-tRNA to the ribosome. Inhibition of eIF2 is mediated by four eIF2␣ kinases that are activated in response to different stress stimuli: the double-stranded RNA-activated protein kinase PKR, which is activated during viral infection; GCN2, which is activated under conditions of amino acid starvation; PERK, which is activated by accumulation of unfolded proteins in the endoplasmic reticulum; and HRI, which couples globin synthesis to heme availability in reticulocytes. Although inhibition of translation can promote cell survival under conditions of endoplasmic reticulum stress or amino acid starvation, the phosphorylation of eIF2␣ by PKR plays a pro-apoptotic role in response to viral infection. Activation of PKR plays a central role in the antiviral response, which includes induction of apoptosis in response to interferon and double-stranded RNA (12) . The best characterized substrate of PKR is eIF2␣, and its phosphorylation leads to inhibition of protein synthesis in virus-infected cells. This inhibition of global translation is critical to induction of apoptosis by PKR, because expression of mutant nonphosphorylatable S51A-eIF2␣ blocks apoptosis induced by PKR overexpression (13) as well as apoptosis induced by several stress stimuli that activate PKR, including double-stranded RNA, interferon, tumor necrosis factor ␣, serum deprivation, and lipopolysaccharide (14 -16) .
Although activation of PKR induces apoptosis through eIF2 inhibition, growth factor signaling through the PI 3-kinase/Akt pathway promotes cell survival in part by maintaining eIF2 activity through regulation of its guanine nucleotide exchange factor, eIF2B (17) . One of the targets of PI 3-kinase/Akt signaling involved in regulation of cell survival is the pro-apoptotic protein kinase GSK-3␤, which is inhibited by Akt phosphorylation (18 -21) . The substrates of GSK-3␤ include eIF2B, which is inhibited as a result of GSK-3␤ phosphorylation (22) (23) (24) . Growth factor deprivation and inhibition of PI 3-kinase leads to activation of GSK-3␤, which then phosphorylates and inhibits eIF2B, resulting in inhibition of translation initiation. Expression of nonphosphorylatable eIF2B mutants suppresses apoptosis induced by GSK-3␤ overexpression, PI 3-kinase inhibition, or growth factor deprivation, indicating that inhibition of eIF2B contributes to apoptosis resulting from inhibition of PI 3-kinase/Akt signaling (17) .
PI 3-kinase/Akt signaling also activates mTOR, which promotes the activity of multiple proteins involved in translation (25) . mTOR regulates the activity of eIF4E (which binds to the 5Ј cap of mRNAs) by phosphorylating eIF4E-binding protein 1 (4E-BP1). In the absence of mTOR signaling, 4E-BP1 binds to eIF4E and inhibits translation initiation. Phosphorylation of 4E-BP1 by mTOR prevents its interaction with eIF4E, coupling PI 3-kinase/Akt and mTOR signaling to translation of capped mRNAs. Overexpression of eIF4E has been shown to inhibit apoptosis induced by several stimuli (26 -28) , whereas overexpression of 4E-BP1 can promote apoptosis (29, 30) . Inhibition of mTOR with rapamycin also induces apoptosis of some tumor cells (31) , although recent studies suggest that this may result from inhibition of Akt activation rather than from direct effects of mTOR on translation (32) . mTOR also stimulates translation by phosphorylation of p70 S6 kinase (25) and regulation of eEF2 kinase (33) , thereby maintaining activity of the elongation factor eEF2. Although roles for the S6 kinases and eEF2 in apoptosis have not been established, the regulation of these additional factors by mTOR demonstrates the complexity of translation regulation by this pathway.
Despite its role in apoptosis induced by several stimuli, the mechanism by which translation inhibition contributes to apoptosis has not been established. One effect of inhibition of translation initiation factors is a selective increase in the translation of some mRNAs containing internal ribosome entry sites or upstream open reading frames (9, 10, 34) . Many proteins that are selectively induced by this mechanism during cell stress either inhibit apoptosis, such as caspase inhibitors XIAP (35) and HIAP2 (36) , or initiate an adaptive program to the cellular stress, such as the transcription factor ATF4 in response to oxidative stress (37) . In addition, some pro-apoptotic proteins have been reported to be induced during translation inhibition, such as Fas and Bax during translation inhibition mediated by PKR (38) , suggesting that selective translation of pro-apoptotic proteins may be one mechanism by which global translation inhibition promotes apoptosis.
However, apoptosis is also induced by inhibition of protein synthesis with cycloheximide in a variety of cells (17, 39 -42) . Because protein synthesis is completely inhibited by cycloheximide, increased translation of pro-apoptotic proteins cannot be responsible for cell death under these conditions. One possibility is that translation inhibition could induce apoptosis by activating a cell stress pathway. Another possibility is that general turnover of cell constituents might lead to deterioration of the cell in an apoptosis-like manner. Alternatively, apoptosis could result from the selective loss of rapidly degraded antiapoptotic regulatory protein(s).
In the present study, we have focused on induction of apoptosis by cycloheximide to analyze the events responsible for apoptosis resulting from inhibition of protein synthesis. We show that translation inhibition activates the mitochondrial pathway of apoptosis because of the loss of a regulatory protein(s) via proteasome-mediated degradation and identify the anti-apoptotic Bcl-2 family member Mcl-1 as a key regulatory protein that couples cell survival to translational regulation.
EXPERIMENTAL PROCEDURES
Cell Culture-Rat-1 fibroblasts were grown in Dulbecco's modified Eagle's medium supplemented with 10% calf serum. PC12 rat pheochromocytoma cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 5% horse serum. HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. T98G human glioblastoma cells were grown in Eagle's minimal essential medium supplemented with 10% fetal bovine serum. U937 human promyelocytic leukemia cells were grown in suspension in RPMI 1640 medium supplemented with 10% fetal bovine serum.
Apoptosis Assay by DNA Fragmentation-Rat-1, PC12, and T98G cells (5 ϫ 10 6 cells/100-mm dish) were plated and U937 cells (3 ϫ 10 6 cells/10 ml) suspended 24 h before treatment with cycloheximide (10 g/ml) and other inhibitors as indicated in the figure legends. The cells were harvested, washed once with phosphate-buffered saline (PBS), and cytosolic nucleic acids isolated as previously described (43) . The resulting nucleic acids were electrophoresed through a 1.5% agarose gel containing ethidium bromide. The gels were treated with 20 g/ml RNase A for 3 h at 37°C prior to visualization by UV transillumination.
Apoptosis Assay by Sub-G 1 Analysis-Following treatment, the cells were harvested (adherent cells were trypsinized to provide a single cell suspension) and centrifuged. The cell pellets were washed twice in 1 ml of PBS and fixed in 1 ml of prechilled 70% ethanol (in PBS) overnight at 4°C. The following day, the cells were washed once with 1 ml of PBS and suspended in 0.5 ml of propidium iodide solution (50 g/ml propidium iodide, 40 g/ml RNase A in PBS). The cell suspensions were incubated 30 min at 37°C in the dark, followed by DNA content analysis by flow cytometry.
Immunoblot Analysis-Proteins were separated by SDSpolyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. Antibodies included anti-Bak NT (06-536; Upstate Biotechnology), anti-Bax (2772; Cell Signaling), anti-Mcl-1 (554103; PharMingen), anti-Bcl-2 (610538; BD Transduction Laboratories), anti-Bcl-x (610746; BD Transduction Laboratories), anti-Bcl-x L (2762; Cell Signaling), antiBim (4582; Cell Signaling), anti-PARP (9542; Cell Signaling), and anti-␤-actin (A5441; Sigma). Western blots were devel-oped using a chemiluminescence reagent (PerkinElmer Life Sciences).
Bak and Bax Activation Assays-U937 cells (20 ϫ 10 6 /50 ml) were suspended in growth medium 24 h before treatment. Following treatment with cycloheximide, the cells were washed once in PBS, suspended in 1 ml of hypotonic RSB buffer (10 mM NaCl, 1.5 mM MgCl 2 , 10 mM Tris-HCl, pH 7.5), and incubated on ice for 10 min. The cells were ruptured with 20 -30 strokes with a tight fitting pestle in a Dounce homogenizer, 0.8 ml of 2.5ϫ MS buffer (525 mM mannitol, 175 mM sucrose, 12.5 mM Tris-HCl, pH 7.5, 2.5 mM EDTA, pH 7.5) was added, and mitochondria were isolated by differential centrifugation. The samples were centrifuged at 1,300 ϫ g for 10 min at 4°C, the supernatants were transferred to clean tubes, and centrifugation was repeated twice. The resulting supernatants were then centrifuged at 17,000 ϫ g for 20 min at 4°C to pellet mitochondria. The mitochondrial pellet was washed once with 0.5 ml of 1ϫ MS buffer and recentrifuged. Cross-linking reactions were then performed on mitochondrial pellets suspended in 675 l of PBS by treatment with 10 mM bismaleimidohexane (Pierce) for 30 min at room temperature (44) . The mitochondria were pelleted and suspended in sample buffer supplemented with 10 mM dithiothreitol to quench the cross-linking reaction. The samples were then subjected to immunoblot analysis to detect oligomeric Bak and Bax.
Transient Transfections and TUNEL Assays-HeLa cells (5 ϫ 10 5 /60-mm plate) were plated 24 h before transfection. The transfections were performed using 6 l of TransIT-LT1 reagent (Mirus)/60-mm plate according to the manufacturer's instructions. The cells were transfected with 1 g of pcDNA3 or the indicated Mcl-1, Bcl-x L , or Bcl-2 expression construct plus 1 g of pCMV-DsRed (BD Biosciences), which expresses a red fluorescent protein. The cells were treated with cycloheximide 24 -48 h after transfection, and TUNEL assays were performed using the Fluorescein FragEL DNA fragmentation detection kit (Calbiochem; catalog number QIA39). The cells were trypsinized and processed according to the manufacturer's recommended protocol for "Fluorescein-FragEL of cell suspensions for flow cytometry." Transfected cells were identified by expression of the DsRed protein with a flow cytometer using the FL2 channel, and the percentage of TUNEL-positive cells were quantified using the FL1 channel.
RNA Interference-RNA interference transfections were conducted using HiPerfect reagent (Qiagen) and indicated predesigned siRNAs (final concentration, 10 nM) from Ambion, Inc. For Mcl-1 RNA interference experiments, the transfection mixtures were prepared in 400 l of total volume by adding 24 l of HiPerfect and either nonspecific siRNA (Ambion negative control siRNA 1, catalog number 4611) or indicated Mcl-1 siRNA (Ambion siRNA I. D. numbers 6126, 6314, and 42844) to serum-free medium, mixed, and incubated at room temperature for 10 min. The transfection mixtures were then transferred to 60-mm plates and overlaid with 4.6 ml of a 10 5 /ml cell suspension in serum-containing medium. The cells were then placed at 37°C, 5% CO 2 for the indicated times before harvest for immunoblot analysis, DNA fragmentation assays, or sub-G 1 analysis. For Bim, Bax, and Bak RNA interference experiments, transfections were conducted as described above, using 200-l total volumes and 12 or 24 l of HiPerfect reagent for the transfection mixtures, which were overlaid with 2.3 ml of a 10 5 /ml cell suspension on 35-mm plates.
All of the siRNAs were purchased from Ambion. Each siRNA consisted of 19-nucleotide double-stranded RNA with two 3Ј-dT overhangs on each strand. siRNA sense sequences and Ambion ID numbers were as follows: Mcl-1 ID 6126, 5Ј-GGA-CACAAAGCCAAUGGGCTT-3Ј; Mcl-1 ID 6314, 5Ј-GGACU-UUUAGAUUUAGUGATT-3Ј; Mcl-1 ID 42844, 5Ј-GGAGGC-CUCGGCCCGGCGATT-3Ј; Bim ID 262307, 5ЈCCUUCUGA-UGUAAGUUCUGTT-3Ј; Bak ID 120199, 5Ј-CCCAGAGAU-GGUCACCUUATT; Bak ID 120201, 5Ј-GCUUUAGCAA-GUGUGCACUTT-3Ј; and Bax ID 213259, 5Ј-GAGGUC-UUUUUCCGAGUGGTT-3Ј.
RESULTS

Apoptosis Induced by Translation Inhibition
Requires Proteasome Activity-If apoptosis in response to translation inhibition occurs because of either the degradation of a specific regulatory protein(s) or nonspecific degradation of cellular constituents, then inhibition of proteolysis should block apoptosis. Because the proteasome is responsible for degradation of most proteins within the cell, the effect of proteasome inhibition on apoptosis resulting from inhibition of protein synthesis was examined in four cell lines: Rat-1 fibroblasts, PC12 rat pheochromocytoma cells, U937 human promyelocytic leukemia cells, and T98G human glioblastoma cells. Rat-1, PC12, and T98G cells were studied as models of growth factor-dependent rodent and human cells (45, 46) , whereas U937 cells were used because they rapidly undergo apoptosis in response to a variety of stimuli and are therefore advantageous for biochemical analysis (47) . Protein synthesis was inhibited by treatment with cycloheximide at a concentration (10 g/ml) that inhibited [ 35 S]methionine incorporation Ͼ95% (data not shown). The cells were pretreated with proteasome inhibitor MG132 for 30 min prior to treatment with cycloheximide for 0 -6 h, after which fragmented cytosolic DNA was isolated and detected by agarose gel electrophoresis. Cycloheximide treatment resulted in rapid and time-dependent apoptosis, detected as early as 2 h after cycloheximide addition, which was blocked by proteasome inhibition with MG132 in all cell lines tested (Fig. 1A) .
DNA content analysis was performed on U937 cells by flow cytometry to quantify the percentage of cells undergoing apoptosis. As shown in Fig. 1 (B and C) , cycloheximide treatment resulted in 25 and 53% cells within the sub-G 1 population at 2 and 4 h, respectively. However, pretreatment with MG132 largely blocked apoptosis, because only 5 and 10% cells were in the sub-G 1 population at 2 and 4 h, respectively.
To ensure that the effects of MG132 were due to its inhibition of the proteasome, U937 cells were pretreated with two other proteasome inhibitors, MG115 and proteasome inhibitor I prior to cycloheximide, both of which also blocked apoptosis through 6 h (Fig. 1D) . Collectively, these studies show that apoptosis induced by cycloheximide requires proteasome activity, indicating that the loss of one or more proteins via proteasomemediated degradation is responsible for apoptosis induced by translation inhibition.
Translation Inhibition Activates the Mitochondrial Pathway of Apoptosis-Protein degradation upon translation inhibition could cause cell death because of a nonspecific global loss of protein, resulting in deterioration of the cell in an apoptosislike manner. Alternatively, cell death could occur through caspase-dependent apoptosis because of the loss of a specific protein, or set of proteins, whose activity normally maintains cell survival by blocking caspase activation directly or indirectly. Treatment of U937 cells with cycloheximide for 6 h resulted in cleavage of the caspase substrate PARP, which was blocked by the general caspase inhibitor zVAD-fmk ( Fig. 2A) , indicating that translation inhibition induces caspase activation. To test whether cell death is dependent on caspase activity, the effect of zVAD-fmk on cycloheximide-induced DNA fragmentation was examined. Pretreatment of Rat-1, U937, and T98G cells with zVAD-fmk blocked apoptosis through 4 h of cycloheximide treatment (Fig. 2B) , indicating that translation inhibition activates an apoptotic program leading to caspasedependent cell death.
Caspase activation during apoptosis typically occurs because of mitochondrial outer membrane permeabilization and release of pro-apoptotic factors including cytochrome c into the cytosol (1). Pap and Cooper (17) previously reported that cycloheximide induces cytochrome c release, suggesting that translation inhibition activates apoptosis through the mitochondrial pathway. In healthy cells, mitochondrial outer membrane permeabilization and cytochrome c release are prevented by anti-apoptotic Bcl-2 proteins. Therefore, to further establish whether translation inhibition activates the mitochondrial pathway of apoptosis, the effect of overexpression of the antiapoptotic Bcl-2 protein Bcl-x L was examined. Because of their high transfectability, HeLa cells were used in this experiment. The cells were transfected with empty vector or a Bcl-x L expression construct. Forty-eight h after transfection, the cells were treated with cycloheximide for 18 h followed by TUNEL analysis in concert with flow cytometry. Although transfection with empty vector resulted in ϳ65% apoptotic cells following cycloheximide treatment, overexpression of Bcl-x L largely blocked apoptosis (Fig. 2C) . These results further indicate that translation inhibition activates the mitochondrial pathway of apoptosis, leading to caspase activation and cell death.
A critical early step in mitochondrial apoptosis is activation of the pro-apoptotic Bcl-2 proteins Bak and/or Bax, which then homo-oligomerize to form pores in the mitochondrial outer membrane (1). If apoptosis following translation inhibition occurs via the mitochondrial pathway, active Bak and/or Bax should be detected upon cycloheximide treatment. Because they homo-oligomerize when activated, active Bak and Bax can be detected by treating mitochondria with the cross-linker bismaleimidohexane prior to SDS-PAGE and immunoblot analysis, resulting in higher molecular weight complexes of active Bak and Bax. As shown in Fig. 3A , oligomeric complexes of both Bak and Bax were detected after 8 h of cycloheximide treatment of U937 cells, indicating that both proteins are activated following translation inhibition. Furthermore, the anti-apoptotic protein(s) degraded by the proteasome appears to act upstream of Bak/Bax activation, because proteasome inhibition with MG132 blocked Bak and Bax activation (Fig. 3B) . Collectively, these results indicate that translation inhibition results in the loss of a protein(s) via proteasome-mediated degradation, resulting in activation of Bak and Bax, caspase activation, and subsequent cell death.
Proteasome-mediated Degradation of Mcl-1 Precedes Bak/ Bax Activation and Apoptosis-Anti-apoptotic
Bcl-2 family proteins maintain cell survival by antagonizing Bak and Bax activation through protein-protein interactions (2) . Therefore, the loss of one or more of these proteins could be responsible for the observed activation of Bak and Bax. Previous studies have shown that the anti-apoptotic Bcl-2 family protein Mcl-1 is rapidly turned over by proteasome-mediated degradation (48 -51) . Therefore, the stability of Mcl-1, as well those of Bcl-2 and Bcl-x L , was assessed following cycloheximide treatment.
Consistent with previous reports, Mcl-1 was rapidly lost with a half-life of less than 2 h in U937, T98G, and HeLa cells (Fig. 4) , whereas both Bcl-2 and Bcl-x L remained largely stable.
If the loss of Mcl-1 is responsible for the activation of Bak and Bax, its loss should precede both Bak/Bax activation and apoptotic events. Therefore, the kinetics of these events were compared in U937 cells following 0 -6 h of cycloheximide treatment. As shown in Fig. 5A (lanes 1-6) , Mcl-1 degradation occurred rapidly with a half-life of ϳ30 min (Fig. 5B) . Importantly, the rapid drop in Mcl-1 preceded the detection of both DNA fragmentation and cleavage of the caspase substrate PARP, which were both first detected at 2 h (Fig. 5A) . Moreover, the time-dependent activation of Bak and Bax was also first detected at 2 h (Fig. 5C) , again following the early drop in Mcl-1 levels.
As expected, proteasome inhibition by pretreatment with MG132 blocked both apoptosis and the loss of Mcl-1 following cycloheximide treatment (Fig. 5, A, lanes 7-11, and B) . However, previous studies have shown that Mcl-1 is cleaved by caspases during apoptosis induced by some stimuli (52) (53) (54) (55) (56) . Although contrary to the observed kinetics, it is conceivable that Mcl-1 might be a target of early caspase activation during apoptosis induced by cycloheximide, in which case MG132 would block Mcl-1 loss indirectly by blocking caspase activation. To rule out this possibility, the effect of caspase inhibition on Mcl-1 stability was assessed. Although caspase inhibition with zVAD-fmk blocked apoptosis, it did not block the loss of Mcl-1 (Fig. 5A, lanes 12-14) . Collectively, these observations further strengthen the hypothesis that the loss of Mcl-1 by proteasome-mediated degradation is, at least in part, responsible Mitochondria were isolated, and cross-linking reactions were performed using the cross-linker bismaleimidohexane, followed by SDS-PAGE and immunoblot analysis to visualize oligomeric Bak and Bax. B, duplicate cultures of U937 cells were left untreated or pretreated with 10 M MG132 for 30 min prior to treatment with 10 g/ml cycloheximide for 6 h. The cells were analyzed as described in A. for Bak/Bax activation and apoptosis following translation inhibition. (Fig. 6A) . This further suggests that the loss of Mcl-1 is a contributing factor to apoptosis. As shown earlier, overexpression of Bcl-x L also blocked apoptosis, whereas overexpression of Bcl-2 provided only a partial block. Immunoblot analysis indicated that Bcl-x L and Bcl-2 were overexpressed at similar levels relative to the respective endogenous proteins (Fig. 6B) (Fig. 7A) . siRNA 6314 yielded Ͼ95% knockdown of Mcl-1 protein compared with nonspecific (NS) siRNA, whereas siRNA 6126 consistently yielded an approximate 50% knockdown, and siRNA 42844 had no effect. Importantly, all three siRNAs had no effect on Bcl-2 or Bcl-x L protein levels.
Mcl-1 Overexpression Blocks Apoptosis Induced by Translation Inhibition-If
Next, the effect of Mcl-1 knockdown with siRNA 6314 on apoptosis was examined in T98G cells. Although transfection of T98G cells with a nonspecific siRNA did not induce apoptosis, knockdown of Mcl-1 with siRNA 6314 was sufficient to induce apoptosis as detected by DNA fragmentation 48 h after transfection (Fig. 7B) . A more thorough analysis of the effects of Mcl-1 knockdown in T98G cells was then conducted in which each of the three siRNAs were transfected for 24 and 48 h. The cells were harvested at each time point and examined for both Mcl-1 protein levels by immunoblot and percentage of apoptotic cells by sub-G 1 analysis (Fig. 7C) at 24 and 48 h, respectively, yielding 15 and 37% apoptotic cells at the same time points. These results demonstrate the importance of maintaining a threshold level of Mcl-1 for cell survival and suggest that drops in Mcl-1 levels following translation inhibition in response to various cellular stresses may be a critical factor contributing to the induction of apoptosis.
Lastly, the effect of near complete knockdown of Mcl-1 was tested in HeLa cells by transfection with Mcl-1 siRNA 6314, which resulted in ϳ24% apoptotic cells at 24 h, as determined by sub-G 1 analysis (Fig. 7D) . However, analysis at 48 h posttransfection revealed similar levels of apoptosis (data not shown), indicating that HeLa cells are less dependent on Mcl-1 for survival than T98G cells.
Knockdown of Bak, Bax, or Bim Protects Cells from Apoptosis Induced by Inhibition of Translation-Most apoptotic stimuli activate pro-apoptotic BH3-only proteins, which then associate with anti-apoptotic Bcl-2 proteins through interactions that displace and activate Bak and Bax (2) . Multiple reports have shown that Mcl-1 interacts with and inhibits the pro-apoptotic BH3-only protein Bim (57) (58) (59) (60) . In addition, Mcl-1 interacts directly with Bak to sequester Bak in an inactive complex (61, 62) . The degradation of Mcl-1 following translation inhibition would thus be predicted to result in the direct activation of both Bak and Bim, with the activation of Bim then leading to subsequent activation of Bax as well as Bak. We therefore tested the roles of these downstream targets of Mcl-1 in apoptosis resulting from inhibition of translation.
RNA interference was used to knockdown Bak, Bax, and Bim in HeLa cells prior to treatment with cycloheximide for 24 h. Transfection with siRNAs resulted in a 5-10-fold knockdown of the respective proteins (Bim is expressed in three isoforms: Bim EL , Bim L , and Bim S (63)) (Fig. 8A) . Apoptosis following cycloheximide treatment was significantly reduced from ϳ50% to 30 -35% apoptotic cells by knockdown of either Bak or Bax (p Ͻ 0.001) (Fig. 8B) , consistent with our earlier observations showing activation of both proteins in response to cycloheximide (Fig. 3) . Knockdown of Bim resulted in a similar inhibition of apoptosis following cycloheximide treatment (p Ͻ 0.001) (Fig. 8C) , indicating that Bim, as well as Bak and Bax, is involved in apoptosis induced by inhibition of translation.
DISCUSSION
The modulation of global translation plays a role in the prosurvival and pro-apoptotic effects of a wide range of cellular stimuli. For example, growth factors promote cell survival, in part, by stimulating translation through activation of the PI 3-kinase/Akt pathway, which activates several components of the translation machinery, including the initiation factors eIF2B and eIF4E (17, 26 -30) . In contrast, several pro-apoptotic stimuli, including double-stranded RNA (produced during viral infection), interferon, lipopolysaccharide, and tumor necrosis factor ␣, induce apoptosis via inhibition of the translation initiation factor eIF2␣ by the protein kinase PKR (13) (14) (15) (16) .
Despite its pro-apoptotic effects in response to various stimuli, the mechanism by which global inhibition of translation promotes apoptosis has not been established. Potential mechanisms include selective translation of pro-apoptotic proteins from mRNAs containing internal ribosome entry sites or upstream open reading frames (10, 38) . However, complete inhibition of translation with cycloheximide induces apoptosis in a wide range of cell types (17, 39 -42) , indicating that translation inhibition can induce apoptosis by a mechanism independent of increased translation of pro-apoptotic proteins. Because endogenous levels of cellular proteins are regulated by their rates of degradation as well as by their rates of translation, selective degradation of anti-apoptotic proteins is another mechanism by which global inhibition of translation could induce apoptosis. In the present study, we have tested this model by examining the induction of apoptosis following inhibition of translation with cycloheximide. Our results indicate that translation inhibition activates the mitochondrial pathway of apoptosis because of degradation of one or more anti-apoptotic proteins via the proteasome and identify the Bcl-2 family protein Mcl-1 as one such protein whose degradation triggers the apoptotic machinery.
The induction of apoptosis by cycloheximide was blocked by proteasome inhibitors in several human and rat cell lines, indicating that selective degradation of cellular proteins was required for apoptosis resulting from inhibition of translation. Multiple observations demonstrated that apoptosis resulting from this proteasome-mediated degradation of cellular proteins was due to specific activation of the mitochondrial pathway of apoptosis rather than a generalized degradation of cellular constituents. First, the induction of apoptosis by cycloheximide was blocked by inhibition of caspases or by overexpression of the anti-apoptotic Bcl-2 family protein Bcl-x L . In addition, cycloheximide induced rapid activation of the pro-apoptotic Bcl-2 proteins Bak and Bax, consistent with previous findings that cycloheximide induced the release of mitochondrial cytochrome c (17) . Inhibition of the proteasome prevented Bak and Bax activation as well as apoptosis, indicating that the degradation of one or more proteins acting upstream of Bak and Bax leads to activation of the mitochondrial pathway of apoptosis.
Bak and Bax are normally antagonized through interactions with anti-apoptotic Bcl-2 proteins, including Bcl-2, Bcl-x L , and Mcl-1 (1) . Previous studies have demonstrated that Mcl-1 is targeted for proteasome-mediated degradation by the E3 ubiquitin ligase MULE (51) Further evidence implicating Mcl-1 degradation in apoptosis induced by cycloheximide was obtained by analysis of its downstream targets. Most stimuli that induce apoptosis lead to activation of pro-apoptotic BH3-only proteins, which then activate Bak and/or Bax (1) . Previous studies have shown that Mcl-1 specifically interacts with the BH3-only protein Bim and inhibits apoptosis, at least in part, by sequestering Bim in an inactive state (57) (58) (59) (60) . In addition, Mcl-1 directly sequesters Bak in an inactive complex (61, 62) . We therefore tested the effects of RNA interference against Bim, Bak, and Bax and found that knockdown of each significantly inhibited apoptosis following cycloheximide treatment. Collectively, these results suggest that degradation of Mcl-1 upon translation inhibition induces apoptosis through the release of both Bim and Bak, with release of Bim then activating Bak and Bax through their displacement from anti-apoptotic Bcl-2 family proteins other than Mcl-1.
We note that this model may account for the differential effects of Bcl-2 and Bcl-x L overexpression on cycloheximideinduced apoptosis. Bcl-x L , like Mcl-1, largely blocked apoptosis resulting from cycloheximide treatment, whereas overexpression of Bcl-2 only inhibited apoptosis by about 50% (Fig. 6) . Bim can interact with Mcl-1, Bcl-x L , and Bcl-2 (69). However, Willis et al. (62) recently demonstrated that although Mcl-1 and Bcl-x L sequester Bak in inactive complexes, Bcl-2 does not. Therefore, overexpression of Bcl-2 may yield incomplete protection because of an inability to sequester Bak released from Mcl-1⅐Bak complexes.
Loss of Mcl-1 has been shown to play a key role in apoptosis induced by adenovirus E1A expression, UV irradiation, and the protein kinase inhibitor BAY 43-9006 (48, 49, 61) . The present findings indicate a general role for loss of Mcl-1 in apoptosis resulting from global inhibition of protein synthesis. It is noteworthy that many apoptotic stimuli, including UV irradiation, inhibit global translation as well as activate one or more pro-apoptotic BH3-only proteins. Because of its rapid degradation, intracellular levels of Mcl-1 are critically affected by translation inhibition, suggesting that Mcl-1 may serve as a convergence point for distinct apoptotic stimuli, directly coupling global translation to cell survival and apoptosis.
